Erratum: Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β (Proceedings of the National Academy of Sciences of the United States of America (June 8, 2004) 101:23 (8705-8708))

Bibiana Bielekova; Nancy Richert; Thomas Howard; Gregg Blevins; Silva Markovic-Plese; Jennifer McCartin; Joseph A. Frank; Jens Würfel; Joan Ohayon; Thomas A. Waldmann; Henry F. McFarland; Roland Martin

doi:10.1073/pnas.0404694101

Erratum: Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β (Proceedings of the National Academy of Sciences of the United States of America (June 8, 2004) 101:23 (8705-8708))

Bibiana Bielekova, Nancy Richert, Thomas Howard, Gregg Blevins, Silva Markovic-Plese, Jennifer McCartin, Joseph A. Frank, Jens Würfel, Joan Ohayon, Thomas A. Waldmann, Henry F. McFarland, Roland Martin

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	17565
Number of pages	1
Journal	Proceedings of the National Academy of Sciences of the United States of America
Volume	101
Issue number	50
DOIs	https://doi.org/10.1073/pnas.0404694101
State	Published - Dec 14 2004
Externally published	Yes

ASJC Scopus subject areas

Genetics
General

Access to Document

10.1073/pnas.0404694101

Cite this

Bielekova, B., Richert, N., Howard, T., Blevins, G., Markovic-Plese, S., McCartin, J., Frank, J. A., Würfel, J., Ohayon, J., Waldmann, T. A., McFarland, H. F., & Martin, R. (2004). Erratum: Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β (Proceedings of the National Academy of Sciences of the United States of America (June 8, 2004) 101:23 (8705-8708)). Proceedings of the National Academy of Sciences of the United States of America, 101(50), 17565. https://doi.org/10.1073/pnas.0404694101

Erratum: Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β (Proceedings of the National Academy of Sciences of the United States of America (June 8, 2004) 101:23 (8705-8708)). / Bielekova, Bibiana; Richert, Nancy; Howard, Thomas et al.
In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, No. 50, 14.12.2004, p. 17565.

Research output: Contribution to journal › Article › peer-review

Bielekova, B, Richert, N, Howard, T, Blevins, G, Markovic-Plese, S, McCartin, J, Frank, JA, Würfel, J, Ohayon, J, Waldmann, TA, McFarland, HF & Martin, R 2004, 'Erratum: Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β (Proceedings of the National Academy of Sciences of the United States of America (June 8, 2004) 101:23 (8705-8708))', Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 50, pp. 17565. https://doi.org/10.1073/pnas.0404694101

Bielekova B, Richert N, Howard T, Blevins G, Markovic-Plese S, McCartin J et al. Erratum: Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β (Proceedings of the National Academy of Sciences of the United States of America (June 8, 2004) 101:23 (8705-8708)). Proceedings of the National Academy of Sciences of the United States of America. 2004 Dec 14;101(50):17565. doi: 10.1073/pnas.0404694101

Bielekova, Bibiana ; Richert, Nancy ; Howard, Thomas et al. / Erratum : Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β (Proceedings of the National Academy of Sciences of the United States of America (June 8, 2004) 101:23 (8705-8708)). In: Proceedings of the National Academy of Sciences of the United States of America. 2004 ; Vol. 101, No. 50. pp. 17565.

@article{2a515e27d88b456097a38b66bacc7cfb,

title = "Erratum: Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β (Proceedings of the National Academy of Sciences of the United States of America (June 8, 2004) 101:23 (8705-8708))",

author = "Bibiana Bielekova and Nancy Richert and Thomas Howard and Gregg Blevins and Silva Markovic-Plese and Jennifer McCartin and Frank, {Joseph A.} and Jens W{\"u}rfel and Joan Ohayon and Waldmann, {Thomas A.} and McFarland, {Henry F.} and Roland Martin",

year = "2004",

month = dec,

day = "14",

doi = "10.1073/pnas.0404694101",

language = "English (US)",

volume = "101",

pages = "17565",

journal = "Proceedings of the National Academy of Sciences of the United States of America",

issn = "0027-8424",

publisher = "National Academy of Sciences",

number = "50",

}

TY - JOUR

T1 - Erratum

T2 - Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β (Proceedings of the National Academy of Sciences of the United States of America (June 8, 2004) 101:23 (8705-8708))

AU - Bielekova, Bibiana

AU - Richert, Nancy

AU - Howard, Thomas

AU - Blevins, Gregg

AU - Markovic-Plese, Silva

AU - McCartin, Jennifer

AU - Frank, Joseph A.

AU - Würfel, Jens

AU - Ohayon, Joan

AU - Waldmann, Thomas A.

AU - McFarland, Henry F.

AU - Martin, Roland

PY - 2004/12/14

Y1 - 2004/12/14

UR - http://www.scopus.com/inward/record.url?scp=10644270726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=10644270726&partnerID=8YFLogxK

U2 - 10.1073/pnas.0404694101

DO - 10.1073/pnas.0404694101

M3 - Article

AN - SCOPUS:10644270726

SN - 0027-8424

VL - 101

SP - 17565

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

IS - 50

ER -

Erratum: Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon β (Proceedings of the National Academy of Sciences of the United States of America (June 8, 2004) 101:23 (8705-8708))

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this